Khaled Nasr's Net Worth

$747 Million

Estimate Recalculated Feb 29, 2024 05:54PM EST

Who is Khaled Nasr?

Khaled Nasr has an estimated net worth of $747 Million. This is based on reported shares across multiple companies, which include CORGENTECH INC, AVEDRO INC, TESARO, Inc., EnteroMedics Inc, Doximity, Inc., Invuity, Inc., Trius Therapeutics Inc, PMV Pharmaceuticals, Inc., GLAUKOS Corp, Braze, Inc., Eiger BioPharmaceuticals, Inc., Carbylan Therapeutics, Inc., Marketo, Inc., OBALON THERAPEUTICS INC, Venus Concept Inc., and Transcept Pharmaceuticals Inc.

SEC CIK

Khaled Nasr's CIK is 0001276600

Past Insider Trading and Trends

2014 was Khaled Nasr's most active year for acquiring shares with 32 total transactions. Khaled Nasr's most active month to acquire stocks was the month of January. 2014 was Khaled Nasr's most active year for disposing of shares, totalling 27 transactions. Khaled Nasr's most active month to dispose stocks was the month of April. 2010 saw Khaled Nasr paying a total of $9,397,557.48 for 3,548,643 shares, this is the most they've acquired in one year. In 2021 Khaled Nasr cashed out on 62,836,091 shares for a total of $174,791,472.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Invuity, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.08M
1.08M
Jun 18
Form 3
0
0
No matching records found

GLAUKOS Corp (GKOS) Snapshot price: $94.51

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.6M
2.6M
Jun 30
Form 3
0
0
No matching records found

Eiger BioPharmaceuticals, Inc. (EIGR) Snapshot price: $6.4

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-14.83%
-237.26K
$12.06
-$2,862,320.82
1.36M
Oct 18
Form 3
0
0
No matching records found

Carbylan Therapeutics, Inc. (KALV) Snapshot price: $14.51

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
4.62M
$5.00
4.62M
Apr 14
Form 3
0
0
No matching records found

Marketo, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-71.64%
-124.48K
$24.31
-$3,006,776.01
49.27K
May 29 - May 30
Form 4
-17.35%
-848.00K
4.04M
May 28
Form 4
-39.07%
-10.00K
$24.01
-$240,090.00
15.6K
May 20 - May 21
Form 4
-36.95%
-15.00K
$22.96
-$344,427.00
25.6K
May 16
Form 4
-100.00%
-34.46K
$24.27
-$836,427.15
0
May 13 - May 14
Form 4
-14.63%
-848.00K
4.95M
May 12
Form 4
-61.95%
-24.42K
$41.96
-$1,024,605.20
15K
Feb 27 - Feb 28
Form 4
-61.55%
-33.05K
$40.33
-$1,334,791.50
20.65K
Feb 26
Form 4
-18.79%
-1.35M
5.85M
Feb 25
Form 4
-100.00%
-4.35K
$40.70
-$177,045.00
0
Feb 13
Form 4
-5.89%
-451.49K
7.21M
Feb 12
Form 4
-21.37%
-2.08M
$33.99
-$70,818,664.12
7.66M
Sep 18
Form 4
9.75M
9.75M
May 22
Form 3
0
0
No matching records found